Smartphone Device Analyzes Semen to Assess Male Fertility

This article originally appeared here.
Share this content:
Smartphone Device Analyzes Semen to Assess Male Fertility
Smartphone Device Analyzes Semen to Assess Male Fertility

THURSDAY, March 23, 2017 (HealthDay News) -- An automated smartphone-based semen analyzer can provide a semen quality evaluation with about 98 percent accuracy, according to research published in the March 22 issue of Science Translational Medicine.

Manoj Kumar Kanakasabapathy, from Brigham and Women's Hospital in Boston, and colleagues report on the development and clinical testing of an automated smartphone-based semen analyzer, which was designed for quantitative measurement of sperm concentration and motility. The assay was designed for point-of-care male infertility screening.

Based on 350 clinical semen specimens at a fertility clinic, the researchers found that the assay can analyze an unwashed unprocessed liquefied semen sample with less than 5 seconds mean processing time. The assay can provide a semen quality evaluation with about 98 percent accuracy based on the World Health Organization guidelines.

"The work suggests that the integration of microfluidics, optical sensing accessories, and advances in consumer electronics, particularly smartphone capabilities, can make remote semen quality testing accessible to people in both developed and developing countries who have access to smartphones," the authors write.

One author is listed an inventor on a patent application submitted by Brigham and Women's Hospital that covers home evaluation of the quality of semen samples.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Amount of Opioids Prescribed After Hospital Discharge Varies

Amount of Opioids Prescribed After Hospital Discharge Varies

45.6 percent of patients using no opioids 24 hours predischarge were prescribed opioids at discharge

Observation Care Cost Saving in Commercially-Insured Patients

Observation Care Cost Saving in Commercially-Insured Patients

Total, out-of-pocket spending considerably lower for observation care; both increased from '09 to '13

Disrupted Sleep Linked to Increased Amyloid- Production

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

is free, fast, and customized just for you!

Already a member?

Sign In Now »